These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 36934104)
1. FBXW7 tumor suppressor regulation by dualspecificity tyrosine-regulated kinase 2. Jiménez-Izquierdo R; Morrugares R; Suanes-Cobos L; Correa-Sáez A; Garrido-Rodríguez M; Cerero-Tejero L; Khan OM; de la Luna S; Sancho R; Calzado MA Cell Death Dis; 2023 Mar; 14(3):202. PubMed ID: 36934104 [TBL] [Abstract][Full Text] [Related]
2. FBXW7: a critical tumor suppressor of human cancers. Yeh CH; Bellon M; Nicot C Mol Cancer; 2018 Aug; 17(1):115. PubMed ID: 30086763 [TBL] [Abstract][Full Text] [Related]
3. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues. Kar R; Jha SK; Ojha S; Sharma A; Dholpuria S; Raju VSR; Prasher P; Chellappan DK; Gupta G; Kumar Singh S; Paudel KR; Hansbro PM; Kumar Singh S; Ruokolainen J; Kesari KK; Dua K; Jha NK Cancer Rep (Hoboken); 2021 Aug; 4(4):e1369. PubMed ID: 33822486 [TBL] [Abstract][Full Text] [Related]
4. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation. Fujii Y; Yada M; Nishiyama M; Kamura T; Takahashi H; Tsunematsu R; Susaki E; Nakagawa T; Matsumoto A; Nakayama KI Cancer Sci; 2006 Aug; 97(8):729-36. PubMed ID: 16863506 [TBL] [Abstract][Full Text] [Related]
5. Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation. Kanei-Ishii C; Nomura T; Takagi T; Watanabe N; Nakayama KI; Ishii S J Biol Chem; 2008 Nov; 283(45):30540-8. PubMed ID: 18765672 [TBL] [Abstract][Full Text] [Related]
6. The HTLV-I oncoprotein Tax inactivates the tumor suppressor FBXW7. Bellon M; Yeh C-h; Bai XT; Nicot C J Virol; 2024 Jul; 98(7):e0040524. PubMed ID: 38874362 [TBL] [Abstract][Full Text] [Related]
7. Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer. Gasca J; Flores ML; Giráldez S; Ruiz-Borrego M; Tortolero M; Romero F; Japón MA; Sáez C Oncotarget; 2016 Aug; 7(33):52751-52765. PubMed ID: 27409838 [TBL] [Abstract][Full Text] [Related]
8. Recent insight into the role of FBXW7 as a tumor suppressor. Yumimoto K; Nakayama KI Semin Cancer Biol; 2020 Dec; 67(Pt 2):1-15. PubMed ID: 32113998 [TBL] [Abstract][Full Text] [Related]
9. Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells. Yeh CH; Bellon M; Wang F; Zhang H; Fu L; Nicot C Mol Cancer; 2020 Sep; 19(1):139. PubMed ID: 32907612 [TBL] [Abstract][Full Text] [Related]
10. Molecular insights and clinical implications for the tumor suppressor role of SCF Qi Y; Rezaeian AH; Wang J; Huang D; Chen H; Inuzuka H; Wei W Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189140. PubMed ID: 38909632 [TBL] [Abstract][Full Text] [Related]
11. E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung cancer cells by inhibiting SOX9 regulation of CDKN1A through ubiquitination. Zhu H; Wang X; Zhou X; Lu S; Gu G; Liu C Lab Invest; 2022 Nov; 102(11):1203-1213. PubMed ID: 35840806 [TBL] [Abstract][Full Text] [Related]
12. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylation-dependent regulation of the NOTCH1 intracellular domain by dual-specificity tyrosine-regulated kinase 2. Morrugares R; Correa-Sáez A; Moreno R; Garrido-Rodríguez M; Muñoz E; de la Vega L; Calzado MA Cell Mol Life Sci; 2020 Jul; 77(13):2621-2639. PubMed ID: 31605148 [TBL] [Abstract][Full Text] [Related]
15. The Role of FBXW7 in Gynecologic Malignancies. Di Fiore R; Suleiman S; Drago-Ferrante R; Subbannayya Y; Suleiman S; Vasileva-Slaveva M; Yordanov A; Pentimalli F; Giordano A; Calleja-Agius J Cells; 2023 May; 12(10):. PubMed ID: 37408248 [TBL] [Abstract][Full Text] [Related]
16. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Asnafi V; Buzyn A; Le Noir S; Baleydier F; Simon A; Beldjord K; Reman O; Witz F; Fagot T; Tavernier E; Turlure P; Leguay T; Huguet F; Vernant JP; Daniel F; Béné MC; Ifrah N; Thomas X; Dombret H; Macintyre E Blood; 2009 Apr; 113(17):3918-24. PubMed ID: 19109228 [TBL] [Abstract][Full Text] [Related]
17. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2. Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854 [TBL] [Abstract][Full Text] [Related]
18. Tumor-suppressor Fbxw7 targets SIK2 for degradation to interfere with TORC2-AKT signaling in pancreatic cancer. Zhang MX; Wang H; Sun GP Cell Biol Int; 2020 Sep; 44(9):1900-1910. PubMed ID: 32437091 [TBL] [Abstract][Full Text] [Related]
19. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E. Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897 [TBL] [Abstract][Full Text] [Related]
20. The Highs and Lows of FBXW7: New Insights into Substrate Affinity in Disease and Development. de la Cova CC Cells; 2023 Aug; 12(17):. PubMed ID: 37681873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]